Open-Label Extension of LOCKCYST Trial

NCT00771888 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Liver Disease
Hepatomegaly
Liver Diseases
Polycystic Kidney
Autosomal Dominant

Interventions

DRUG: lanreotide

Sponsor

Radboud University Medical Center

Collaborators

[object Object]